Allogeneic Blood or Marrow Transplantation (AlloBMT) with High-Dose Post-Transplantation Cyclophosphamide (PTCy) for Acute Lymphoblastic Leukemia (ALL) in Patients Aged ≥ 55: Best Results in B ALL in First Remission (CR1) with Reduced-Intensity Conditioning (RIC)

Subjects

Subjects :

Immunology
Cell Biology
Hematology
Biochemistry

Details

ISSN :

15280020 and 00064971

Volume :

140

Database :

OpenAIRE

Journal :

Blood

Accession number :

edsair.doi...........ab4a56b16b86015e1b06eb3179b406d7

Full Text :

https://doi.org/10.1182/blood-2022-171038